Banstag Lifesciences Private Limited

Manufactures and distributes a wide range of pharmaceutical and healthcare products.

2018 | Chandigarh (India) | Inactive
Last Updated: January 17, 2025

Banstag Lifesciences Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 2 Months
  • Last Filing with ROC 31 Mar 2023

About Banstag Lifesciences

Banstag Lifesciences Private Limited (BLPL) is Strike Off company established on 05 Nov 2018 with its office registered at Chandigarh, India and has been running since 6 Year, 2 Months with a paid up capital of 0.10 M. According to MCA records, 3 Directors are linked to this company as of 17 Jan 2025.

Company Details

  • Location

    Chandigarh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U74999CH2018PTC042248

  • Company No.

    042248

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    05 Nov 2018

  • Date of AGM

    31 Aug 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Chandigarh

Industry

Pharma

Who are the key members and board of directors at Banstag Lifesciences?

Board Members (3)

Name Designation Appointment Date Status
Rajan Singla Country flag representing In Director 01-Jun-2021 Current
Sunil Bansal Country flag representing In Director 05-Nov-2018 Current
Suresh Kumar Country flag representing In Director 05-Nov-2018 Current

Financial Performance of Banstag Lifesciences.

Banstag Lifesciences Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Banstag Lifesciences?

In 2019, Banstag Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Banstag Lifesciences?

Unlock and access historical data on people associated with Banstag Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Banstag Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Banstag Lifesciences's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Banstag Lifesciences

Recent activity within the organization

  • Annual General Meeting

    Banstag Lifesciences Private Limited last Annual general meeting of members was held on 31 Aug 2023 as per latest MCA records.

    31 Aug 2023

  • Balance Sheet

    Banstag Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chandigarh.

    31 Mar 2023

  • Director Appointment

    Rajan Singla was appointed as a Director was appointed as a Director on 01 Jun 2021 & has been associated with this company since 3 years 8 months .

    01 Jun 2021

  • Director Appointment

    Sunil Bansal was appointed as a Director was appointed as a Director on 05 Nov 2018 & has been associated with this company since 6 years 2 months .

    05 Nov 2018

  • Director Appointment

    Suresh Kumar was appointed as a Director was appointed as a Director on 05 Nov 2018 & has been associated with this company since 6 years 2 months .

    05 Nov 2018

  • Company Incorporation

    Banstag Lifesciences Private Limited was registered on 05 Nov 2018 with Roc Chandigarh & aged 6 years 2 months as per MCA records.

    05 Nov 2018

Frequently asked questions

  • Banstag Lifesciences Private Limited was incorporated on 05 Nov 2018.

  • The authorized share capital of Banstag Lifesciences Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.

  • Currently 3 directors are associated with Banstag Lifesciences Private Limited.

    • Sunil Bansal
    • Suresh Kumar
    • Rajan Singla
  • As per Ministry of Corporate Affairs (Mca), the registered address of Banstag Lifesciences Private Limited is 170 F.F Sector 18A India, Chandigarh, 160018.

  • The corporate identification number (CIN) of Banstag Lifesciences Private Limited is U74999CH2018PTC042248 and the company number is 042248 as per Ministry of Corporate Affairs (MCA).

  • The most recent Balance Sheet for Banstag Lifesciences Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development